Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma

被引:153
作者
Tarpey, Patrick S. [1 ]
Behjati, Sam [1 ,2 ]
Cooke, Susanna L. [1 ]
Van Loo, Peter [1 ,3 ,4 ]
Wedge, David C. [1 ]
Pillay, Nischalan [5 ,6 ]
Marshall, John [1 ]
O'Meara, Sarah [1 ]
Davies, Helen [1 ]
Nik-Zainal, Serena [1 ]
Beare, David [1 ]
Butler, Adam [1 ]
Gamble, John [1 ]
Hardy, Claire [1 ]
Hinton, Jonathon [1 ]
Jia, Ming Ming [1 ]
Jayakumar, Alagu [1 ]
Jones, David [1 ]
Latimer, Calli [1 ]
Maddison, Mark [1 ]
Martin, Sancha [1 ]
McLaren, Stuart [1 ]
Menzies, Andrew [1 ]
Mudie, Laura [1 ]
Raine, Keiran [1 ]
Teague, Jon W. [1 ]
Tubio, Jose M. C. [1 ]
Halai, Dina [5 ]
Tirabosco, Roberto [5 ]
Amary, Fernanda [5 ]
Campbell, Peter J. [1 ,7 ,8 ]
Stratton, Michael R. [1 ]
Flanagan, Adrienne M. [5 ,6 ]
Futreal, P. Andrew [1 ]
机构
[1] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England
[2] Univ Cambridge, Dept Paediat, Cambridge, England
[3] VIB, Dept Human Genet, Human Genome Lab, Louvain, Belgium
[4] Katholieke Univ Leuven, Louvain, Belgium
[5] Royal Natl Orthopaed Hosp Natl Hlth Serv NHS Trus, Stanmore, Middx, England
[6] UCL, Inst Canc, London, England
[7] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
[8] Univ Cambridge, Dept Haematol, Cambridge, England
基金
英国惠康基金;
关键词
RECEPTOR; PATHWAY; CANCER; TUMORS; MICE;
D O I
10.1038/ng.2668
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chondrosarcoma is a heterogeneous collection of malignant bone tumors and is the second most common primary malignancy of bone after osteosarcoma. Recent work has identified frequent, recurrent mutations in IDH1 or IDH2 in nearly half of central chondrosarcomas. However, there has been little systematic genomic analysis of this tumor type, and, thus, the contribution of other genes is unclear. Here we report comprehensive genomic analyses of 49 individuals with chondrosarcoma (cases). We identified hypermutability of the major cartilage collagen gene COL2A1, with insertions, deletions and rearrangements identified in 37% of cases. The patterns of mutation were consistent with selection for variants likely to impair normal collagen biosynthesis. In addition, we identified mutations in IDH1 or IDH2 (59%), TP53 (20%), the RB1 pathway (33%) and Hedgehog signaling (18%).
引用
收藏
页码:923 / U293
页数:5
相关论文
共 25 条
[1]  
Aceto Gitana, 2005, Hum Mutat, V26, P394, DOI 10.1002/humu.9370
[2]   CLONING OF THE PUTATIVE TUMOR-SUPPRESSOR GENE FOR HEREDITARY MULTIPLE EXOSTOSES (EXT1) [J].
AHN, J ;
JOSEFLUDECKE, H ;
LINDOW, S ;
HORTON, WA ;
LEE, B ;
WAGNER, MJ ;
HORSTHEMKE, B ;
WELLS, DE .
NATURE GENETICS, 1995, 11 (02) :137-143
[3]   IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours [J].
Amary, M. Fernanda ;
Bacsi, Krisztian ;
Maggiani, Francesca ;
Damato, Stephen ;
Halai, Dina ;
Berisha, Fitim ;
Pollock, Robin ;
O'Donnell, Paul ;
Grigoriadis, Anita ;
Diss, Tim ;
Eskandarpour, Malihe ;
Presneau, Nadege ;
Hogendoorn, Pancras C. W. ;
Futreal, Andrew ;
Tirabosco, Roberto ;
Flanagan, Adrienne M. .
JOURNAL OF PATHOLOGY, 2011, 224 (03) :334-343
[4]   Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation [J].
Barbieri, O ;
Astigiano, S ;
Morini, M ;
Tavella, S ;
Schito, A ;
Corsi, A ;
Di Martino, D ;
Bianco, P ;
Cancedda, R ;
Garofalo, S .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (06) :C1504-C1512
[5]   Inactivation of Patched1 in the Mouse Limb Has Novel Inhibitory Effects on the Chondrogenic Program [J].
Bruce, Stephen J. ;
Butterfield, Natalie C. ;
Metzis, Vicki ;
Town, Liam ;
McGlinn, Edwina ;
Wicking, Carol .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (36) :27967-27981
[6]   Differential Effect of ECM Molecules on Re-Expression of Cartilaginous Markers in Near Quiescent Human Chondrocytes [J].
Chiu, Li-Hsuan ;
Chen, Shih-Ching ;
Wu, Kai-Chen ;
Yang, Charng-Bin ;
Fang, Chia-Lang ;
Lai, Wen-Fu T. ;
Tsai, Yu-Hui .
JOURNAL OF CELLULAR PHYSIOLOGY, 2011, 226 (08) :1981-1988
[7]   Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response [J].
Fathi, Amir T. ;
Sadrzadeh, Hossein ;
Borger, Darrell R. ;
Ballen, Karen K. ;
Amrein, Philip C. ;
Attar, Eyal C. ;
Foster, Julia ;
Burke, Meghan ;
Lopez, Hector U. ;
Matulis, Christina R. ;
Edmonds, Katherine M. ;
Iafrate, A. John ;
Straley, Kimberly S. ;
Yen, Katharine E. ;
Agresta, Samuel ;
Schenkein, David P. ;
Hill, Cedric ;
Emadi, Ashkan ;
Neuberg, Donna S. ;
Stone, Richard M. ;
Chen, Yi-Bin .
BLOOD, 2012, 120 (23) :4649-4652
[8]   Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors [J].
Hallor, Karolin H. ;
Staaf, Johan ;
Bovee, Judith V. M. G. ;
Hogendoorn, Pancras C. W. ;
Cleton-Jansen, Anne-Marie ;
Knuutila, Sakari ;
Savola, Suvi ;
Niini, Taria ;
Brosjo, Otte ;
Bauer, Henrik C. F. ;
von Steyern, Fredrik Vult ;
Jonsson, Kjell ;
Skorpil, Mikael ;
Mandahl, Nils ;
Mertens, Fredrik .
CLINICAL CANCER RESEARCH, 2009, 15 (08) :2685-2694
[9]   A mutant PTH/PTHrP type I receptor in enchondromatosis [J].
Hopyan, S ;
Gokgoz, N ;
Poon, R ;
Gensure, RC ;
Yu, CY ;
Cole, WG ;
Bell, RS ;
Jüppner, H ;
Andrulis, IL ;
Wunder, JS ;
Alman, BA .
NATURE GENETICS, 2002, 30 (03) :306-310
[10]   Transcription as a source of genome instability [J].
Kim, Nayun ;
Jinks-Robertson, Sue .
NATURE REVIEWS GENETICS, 2012, 13 (03) :204-214